Items Tagged ‘AI’

November 15th, 2016

Aromatase Inhibitor–Associated Joint Pain Tends to Resolve Upon Treatment Completion

By

A class of drugs known as aromatase inhibitors (AI) commonly used in the management of estrogen receptor-positive (ER+) breast cancer are associated with troublesome joint pain. In fact, as many as half of women on AI therapy experience joint pain, and 20% become non-compliant with their AI therapy because of side effects.1 The origin of […]

View full entry

Tags: AI, aromatase inhibitors, Breast Cancer, ER-positive, joint pain, News


October 28th, 2015

The Type of Breast Cancer Determines Effectiveness of Different Hormonal Therapies

By

According to the results of a recent study published in the Journal of Clinical Oncology, women with certain subtypes of hormone-positive breast cancer appear to benefit differently when treated with hormone therapy. Hormone-positive breast cancer refers to breast cancer that is stimulated to grow from the female hormone, estrogen. Therefore, a standard treatment component for […]

View full entry

Tags: AI, anti-estrogen agent, aromatase inhibitors, Breast Cancer, Femara, hormone-positive breast cancer, IDC, ILC, letrozole, News, tamoxifen


December 12th, 2014

Exercise Significantly Reduces Joint Pain Caused by Hormone Therapy Taken by Patients With Breast Cancer

By

According to a study published this week in the Journal of Clinical Oncology regular exercise helps relieve arthritic joint pain associated with aromatase inhibitor (AI) drugs used to treat breast cancer.1 Aromatase inhibitors are widely used in the treatment of estrogen receptor positive early and late stage breast cancer, and can also reduce the likelihood […]

View full entry

Tags: AI, arthritic, Breast Cancer, exercise, News, Stage I Node Negative Breast Cancer, Stages II-III Breast Cancer